AIImpactLab
9 impact clustersWork & marketsCognition & learningTechnical failuresPrivacySecurityEnvironmentLaw & informationSocial good & healthSystemic risk
Search the evidence

Find the signal.

Search titles, impact clusters, countries, organizations and the full text of every analysis.

4 stories found

Work & marketsGlobal+2 clusters01

Huang et al., “Autonomous biomedical research with an artificial intelligence agent”

The paper introduces Biomni, a general-purpose biomedical agent that can search literature, formulate hypotheses, select datasets and specialized tools, write analytical code, interpret results, and propose subsequent experiments within an integrated workflow. Stanford reports that a prototype is already used by more than 10,000 laboratories; in one example, it processed over 450 wearable-health files and generated plausible findings in 40 minutes, compared with an estimated 60 or more hours of human work.

2 min
Social good & healthUnited States+3 clusters02

A $5 billion federal push links AI to health, infrastructure and science

The U.S. government has committed more than $5 billion to expand the Genesis Mission, a multi-agency effort that combines federal datasets, Department of Energy supercomputers, research facilities, and AI tools. More than 15 agencies and 278 selected projects will target problems including chronic disease, pediatric cancer, drug discovery, resilient building materials, transportation maintenance, energy, manufacturing, agriculture, and national security.

3 min
Technical failuresGlobal+1 clusters03

Nature multi-agent scientific-discovery papers

A new Nature News & Views piece highlights two 2026 Nature papers showing AI agents moving from literature support toward hypothesis generation, experiment planning, and data analysis. One paper introduces Robin, a multi-agent system that generated hypotheses, proposed experiments, interpreted results, and identified therapeutic candidates for dry age-related macular degeneration; another introduces Google/DeepMind’s Gemini-based Co-Scientist, with affiliations including Stanford University School of Medicine and Imperial College London, and reports experimentally validated biomedical hypotheses including acute myeloid leukemia drug-repurposing and combination-therapy candidates.

2 min
Technical failuresGlobal+1 clusters04

TRUECAM uncertainty-aware cancer-diagnostics framework

Nature Biomedical Engineering published a lung-cancer pathology AI paper introducing TRUECAM, a framework that detects out-of-scope inputs, filters ambiguous regions, and uses conformal prediction to control error rates; the authors report gains in accuracy, robustness, interpretability, data efficiency, and fairness across datasets and foundation models. its significance is less “AI replaces diagnosis” than “AI deployment requires uncertainty, fairness, and error-control layers.”

2 min